Evidence map›Paper›PMID 30483881›Full record

ArticleJournal of neurology2019

Association between the missense alcohol dehydrogenase rs1229984T variant with the risk for Parkinson's disease in women.

Elena García-Martín, Mónica Diez-Fairen, Pau Pastor, Javier Gómez-Tabales, Hortensia Alonso-Navarro, Ignacio Alvarez, María Cárcel, Miquel Aguilar, José A G Agúndez, Félix Javier Jiménez-Jiménez

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Lack of Association BetweenInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Association between LAG3/CD4 gene variants and risk of Parkinson's disease.European journal of clinical investigation · 2022
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Elena García-MartínUniversity Institute of Molecular Pathology Biomarkers, UNEx, ARADyAL, Cáceres, Spain.
Mónica Diez-FairenFundació per la Recerca Biomèdica i Social Mútua de Terrassa, Terrassa, Barcelona, Spain.
Pau PastorFundació per la Recerca Biomèdica i Social Mútua de Terrassa, Terrassa, Barcelona, Spain.
Javier Gómez-TabalesUniversity Institute of Molecular Pathology Biomarkers, UNEx, ARADyAL, Cáceres, Spain.
Hortensia Alonso-NavarroSection of Neurology, Hospital Universitario del Sureste, Ronda del Sur 10, 28500, Arganda del Rey, Madrid, Spain.
Ignacio AlvarezFundació per la Recerca Biomèdica i Social Mútua de Terrassa, Terrassa, Barcelona, Spain.
María CárcelFundació per la Recerca Biomèdica i Social Mútua de Terrassa, Terrassa, Barcelona, Spain.
Miquel AguilarFundació per la Recerca Biomèdica i Social Mútua de Terrassa, Terrassa, Barcelona, Spain.
José A G AgúndezUniversity Institute of Molecular Pathology Biomarkers, UNEx, ARADyAL, Cáceres, Spain.
Félix Javier Jiménez-JiménezSection of Neurology, Hospital Universitario del Sureste, Ronda del Sur 10, 28500, Arganda del Rey, Madrid, Spain. fjavier.jimenez@salud.madrid.org.ORCID http://orcid.org/0000-0002-7558-7323
Mútua Terrassa · ESHospital Universitario del Sureste · ESHospital Universitario Príncipe de Asturias · ES

Funding

Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain PI15/00303Fondo de Investigación Sanitaria, Instituto de Salud Carlos III, Madrid, Spain RETICS RD16/0006/0004Junta de Extremadura, Mérida, Spain GR18145Junta de Extremadura, Mérida, Spain IB16170Spanish Ministry of Science and Innovation SAF2006-10126Spanish Ministry of Science and Innovation SAF2010-22329-C02-01
6 · The paper itself

Abstract

BACKGROUND/

objectiveSeveral meta-analyses including retrospective case-control studies have shown that the risk of developing Parkinson's disease (PD) correlates inversely with alcohol consumption and (PD), although the results of prospective longitudinal studies are far from being conclusive. The reasons for this inverse association are not well-known. Because alcohol dehydrogenase is one of the most important alcohol-detoxification enzymes, we tried to replicate a putative association of the risk of developing PD with two missense gene variations affecting the alcohol dehydrogenase 1B (ADH1B) gene (one of them related with aversive effects to alcohol).

methodsIn a cohort composed of 629 PD patients and 865 age- and gender-matched healthy individuals, we analyzed genotypes and allele frequencies for two common missense ADH1B single nucleotide polymorphisms (SNPs), namely rs1229984 (His48Arg) and rs6413413 (Thr60Ser) using specifically designed TaqMan assays.

resultsThe frequency of individuals carrying rs1229984T alleles in homozygosity or in heterozygosity was higher in PD than in controls in the whole study cohort (P < 0.001 and P = 0.005, respectively), and in women (P < 0.001 and P < 0.001, respectively). The genotypes for rs6413413 were similar in PD patients and control subjects. Age at onset of PD patients was not statistically related to rs1229984 or rs6413413 genotypes.

conclusionsThe missense variant rs1229984T is statistically associated with the risk of developing PD mainly in women, which could explain differences in alcohol consumption in this gender.

Indexed as

AdultAgedAged, 80 and overAlcohol DehydrogenaseAlcohol DrinkingFemaleHumansMaleMiddle AgedMutation, MissenseParkinson DiseasePolymorphism, Single NucleotideRiskSpainYoung AdultADH1B protein, humanAlcohol DehydrogenaseADH1B geneGeneticsParkinson’s diseasePolymorphismsRisk factors

Identifiers

PMID30483881
OpenAlexW2903289055

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.